GEISTWERT Rechtsanwälte Lawyers Avvocati

UPC_CFI_195/2025

Sanofi Biotechnologies SAS v. Amgen Inc. a. o.

Date
2026-06-08
Division
Düsseldorf (DE) Local Division
Type of action
Infringement Action
Language
EN

Metadata

Case IDUPC_CFI_195-2025-7c35fa8849ba
Case number
Registry numberUPC_CFI_195/2025
Order reference
Keywords
Headnotes

Documents and full text

Extractor: pypdf | Pages: 5

1 Düsseldorf Local Division UPC_CFI_195/2025 UPC_CFI_568/2026 Decision of the Court of First Instance of the Unified Patent Court issued on 8 June 2026 concerning EP 4 252 857 CLAIMANTS: 1. Sanofi Biotechnologies SAS, 82 avenue Raspail, 94250 Gentily, France, represented by its chairman, Laurent Gilhodes, 2. Regeneron Pharmaceuticals Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591, United States of America, represented by its CEO Leonard Schleifer, all Claimants represented by: Dr. Niels Hölder, Mike Gruber, Dr. Michael Pfeifer and all other UPC Represenatives of HOFFMANN EITLE PartmbB, Daniel Wise, Agathe Michel-de Cazotte and all other UPC Rep- resentatives of CARPMEALS & RANSFORD, 1 Southampton Row WC1B 5HA London, United Kingdom, electronic address for service: nhoelder@ho ...